Aucta Pharmaceuticals, Inc.
3 drugs in NADAC|0 Generic,3 Brand
Aucta Pharmaceuticals, Inc. lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $21.48 per unit. The firm's full portfolio, pricing trend are listed below.
Total Drugs
3
0G / 3B
Avg Price / Unit
$21.4810
$21.43 – $21.51
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
lacosamide market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Aucta Pharmaceuticals, Inc. make?
Aucta Pharmaceuticals, Inc. lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.
What is the average price of Aucta Pharmaceuticals, Inc. drugs?
The average NADAC across Aucta Pharmaceuticals, Inc.'s portfolio is $21.4810 per unit, ranging from $21.4301 to $21.5109.
Has Aucta Pharmaceuticals, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Aucta Pharmaceuticals, Inc. in the openFDA feed.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MOTPOLY XR 200 MG CAPSULE lacosamide | $21.5109 per EA | — |
MOTPOLY XR 150 MG CAPSULE lacosamide | $21.5019 per EA | — |
MOTPOLY XR 100 MG CAPSULE lacosamide | $21.4301 per EA | — |